Research Article
Clinico-Microbiological Profile and Treatment Outcome of Infectious Scleritis: Experience from a Tertiary Eye Care Center of India
Table 2
Results of antibiotic susceptibility testing for bacterial isolates (Kirby Bauer disc diffusion method).
| Sl. no | Patient no. (from Table 1) | Name of the bacteria | Antibiotics | | | | Chlo | Cefa | Vanco | Cipro | Gati | Oflo | Amik |
| 1 | 1 | S. aureus | S | ND | ND | S | S | ND | ND | 2 | 2 | Nocardia sp. | S | S | ND | S | S | ND | S | 3 | 3 | Atypical mycobacteria | S | S | S | S | S | ND | S | 4 | 6 | S. pneumoniae | S | S | S | S | S | S | ND | 5 | 7 | Staphylococcus sp. | S | S | S | R | S | I | ND | 6 | 8 | S. aureus | S | S | S | I | I | I | ND | 7 | 9 | P. aeruginosa | R | ND | ND | S | S | S | S | 8 | 10 | Nocardia sp. | R | R | R | S | S | S | S | 9 | 11 | S. aureus | R | S | S | R | I | I | ND | 10 | 12 | S. pneumoniae | S | S | S | S | S | S | ND | 11 | 13 | Atypical mycobacteria | R | R | R | R | R | R | S | 12 | 14 | Nocardia sp. | S | R | S | R | S | R | S | 13 | 16 | S. aureus | S | S | S | I | S | I | ND |
|
|
Chlo: Chloramphenicol, Cefa: Cefazolin, Vanco: Vancomycin, Cipro: Ciprofloxacin, Gati: Gatifloxacin, Oflox: Ofloxacin, Amik: Amikacin, S: Sensitive, I: Intermediate, R: Resistant, ND: Not done.
|